Search

Home > Industry Focus > Healthcare: Why Marijuana Stock HEXO Is on the Hot Seat. And, What's Behind Mylan's Mega-Merger With Pfizer
Podcast: Industry Focus
Episode:

Healthcare: Why Marijuana Stock HEXO Is on the Hot Seat. And, What's Behind Mylan's Mega-Merger With Pfizer
Category: Business
Duration: 00:33:09
Publish Date: 2019-07-31 14:30:00
Description:

Pot stock HEXO is under fire over its use of social media advertising and if that isn't bad enough, its home province, Quebec, has proposed restrictions on marijuana edibles that could disrupt its growth plans. Is it game over for HEXO? Also, here's why  biopharma giant Pfizer is merging its off-patent drug portfolio with generic drug heavy weight Mylan. 

Check out more of our content here:
Total Play: 0

Users also like

0 Episodes
MarketFooler .. 100+     6
700+ Episodes
Rule Breaker .. 200+     6
2K+ Episodes
Motley Fool .. 300+     10+

Some more Podcasts by The Motley Fool

300+ Episodes
Motley Fool ..    
700+ Episodes
Rule Breaker .. 200+     6
400+ Episodes
Motley Fool .. 100+     5
2K+ Episodes
Motley Fool .. 300+     10+
2K+ Episodes
Motley Fool ..